ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,581Review JournalHybrid

Seminars in Liver Disease

Acronym:sld
•
Abbreviation (ISO):SEMIN LIVER DIS
•
Identifier (ISSN):0272-8087(Print)/1098-8971(Online)
•
Publisher:Thieme Medical Publishers
Clarivate IF (2026)
4↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Seminars in Liver Disease

WoS Q2
24794.1720183.4620194.4620206.1220216.5120224.220234.320243.7202542026
Annual Impact Factor Metric
Current (2026):4
Scopus SJR & RankScopus Q1
1.45
#2,581

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
146

146 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
52articles/year
21.7% Gold OA•0% Original Research

Aims & Scope

Seminars in Liver Disease is a quarterly review journal that publishes issues related to the specialties of hepatology and gastroenterology. As the premiere review journal in the field, Seminars in Liver Disease provides in-depth coverage with articles and issues focusing on topics such as cirrhosis, transplantation, vascular and coagulation disorders, cytokines, hepatitis B & C, Nonalcoholic Steatosis Syndromes (NASH), pediatric liver diseases, hepatic stem cells, porphyrias as well as a myriad of other diseases related to the liver. Attention is also given to the latest developments in drug therapy along with treatment and current management techniques. Seminars in Liver Disease publishes commissioned reviews. Unsolicited reviews of an exceptional nature or original articles presenting remarkable results will be considered, but case reports will not be published.

Topics Covered (Recognized by AI)
Medicine97.2%Biology80%Internal medicine78.5%Chemistry54.2%Genetics53.7%Biochemistry51.6%Pathology49.3%Gastroenterology48.3%Immunology41.1%Surgery31.5%Endocrinology28.7%Disease26.9%Virology22.7%Cirrhosis22.7%Intensive care medicine20.6%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

GASTROENTEROLOGY & HEPATOLOGY

Q2
Rank42/153
IndexSCIE
JCISCIE2026

GASTROENTEROLOGY & HEPATOLOGY

Q2
Rank73/153
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4
Articles / Year8
Total Citations210
2025
IF3.7
Articles / Year36
Total Citations110
2024
IF4.3
Articles / Year47
Total Citations294
2023
IF4.2
Articles / Year38
Total Citations330
2022
IF6.512
Articles / Year43
Total Citations723

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,581Scopus Q1SCImago Profile
Scopus Coverage:1981-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.45

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.78

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,666 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations495
3-Year Documents118
Citable Documents118

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HepatologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区GASTROENTEROLOGY & HEPATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Seminars in Liver Disease (acronym: sld, abbr: SEMIN LIVER DIS, ISSN: 0272-8087) is a peer-reviewed international scholarly journal in the field of Medicine, published by Thieme Medical Publishers in United States since 1981. The periodical holds a Journal Impact Factor (JIF) of 4.00, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.450 (Q1), an H-index of 146.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 52 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,666 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Thieme Medical Publishers
Publication Language
English
Frequency
Quarterly
Founding Year
1981
Indexing & Databases
SCIEScopusPubMed
Editorial Address
THIEME MEDICAL PUBL INC, 333 SEVENTH AVE, NEW YORK, USA, NY, 10001

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7e49f610-ca37-41da-98b2-3ae085344df8
Database Updated: 2026-10-01